• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Ocufen (flurbiprofen sodium ophthalmic solution, USP)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – July 2012

 

Summary View

 

ADVERSE REACTIONS

  • ...ocular hyperemia. Increased bleeding tendency of ocular tissues in conjunction with ocular surgery has also been reported.